Mohammad Naderi - Infectious Diseases

Author Information

Mohammad Naderi is affiliated with the Infectious Diseases and Tropical Medicine Research Center, part of the Resistant Tuberculosis Institute at Zahedan University of Medical Sciences in Zahedan, Iran. His research primarily focuses on the genetic and molecular aspects of infectious diseases, with a particular emphasis on tuberculosis and COVID-19.

Research Contributions

Mohammad Naderi has made significant contributions to the understanding of genetic polymorphisms and their association with infectious diseases. His work includes the study of various gene polymorphisms such as those in the angiotensinogen, angiotensin-converting enzyme, NOD2, MBL2, P2X7, CD1A, CD1D, and FTO genes. His research has largely concentrated on populations in Southeast Iran, providing valuable insights into the genetic susceptibility to diseases like tuberculosis and COVID-19 in this region.

Aliases

Mohammad Naderi is sometimes referred to by the alias "M. Naderi" in his publications.

Publication and Citation Metrics

Metric	Value
Citation Count	869
h-index	18
Paper Count	62

Publications:

Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study

DOI: 10.1186/s41231-021-00106-0

Year: 2021

Association between NOD2 gene polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast Iran

DOI: 10.1016/j.genrep.2021.101395

Year: 2021

Association Study of MBL2 Gene Polymorphisms and Risk of Tuberculosis in Southeast of Iran.

DOI: 10.14712/23362936.2020.20

Year: 2020

Association between P2X7 Polymorphisms and Susceptibility to Tuberculosis: An Updated Meta-Analysis of Case-Control Studies

DOI: 10.3390/medicina55060298

Year: 2019

Association between genetic variants in CD1A and CD1D genes and pulmonary tuberculosis in an Iranian population.

DOI: 10.3892/BR.2019.1201

Year: 2019

Macrophage migration inhibitory factor -173 G > C polymorphism and risk of tuberculosis: A meta-analysis

DOI: 10.17179/excli2016-662

Year: 2017

Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.

DOI: 10.2174/1874467209666160112123746

Year: 2017

Comparison of Serum Leptin Levels in Pulmonary Tuberculosis Patients with Acute Pneumonia Patients and Healthy Individuals

DOI:

Year: 2017

Association study of the FTO gene polymorphisms with the risk of pulmonary tuberculosis in a sample of Iranian population.

DOI: 10.1556/030.64.2017.010

Year: 2017

Macrophage migration inhibitory factor -173 G > C polymorphism and risk of tuberculosis

DOI: 10.17877/DE290R-18119

Year: 2017

How Is Muscle and Joint Pain Diagnosed in the Context of Infectious Diseases?

What Are the Components of the DTaP Vaccine?

What is a Retrovirus?

What are Common Symptoms of Infectious Diseases?

Can the Inflammatory Response be Modulated?

How is Ebola Diagnosed?

Are Some Environments More Conducive to the Spread of Respiratory Droplets?

How Do Apicomplexan Parasites Infect Hosts?

What Are Common Infectious Diseases Screened During Check-Ups?

What are Inhibitors and How Do They Work?

Partnered Content Networks

Relevant Topics